Dimitri E. Grigoriadis

Dimitri E. Grigoriadis is the current Chief Research Officer at Neurocrine Biosciences. Prior to this, they worked at The DuPont Pharmaceutical Company from September 1990 to June 1993 as a Sr. Principal Scientist. Dimitri has extensive experience in the pharmaceutical industry, making him a valuable asset to Neurocrine Biosciences. Dimitri is dedicated to their work and is constantly looking for new ways to improve the products and services that their company offers.

Dimitri E. Grigoriadis has a Ph.D. in Pharmacology from the University of Toronto, an M.Sc. in Pharmacology from the University of Toronto, and a Cert. Hon. Standing in Pharmacology from Western University. Dimitri also has a B.Sc. in General Science from the University of Guelph.

Dimitri E. Grigoriadis works with Eiry W. Roberts - Chief Medical Officer, David W. Boyer - Chief Corporate Affairs Officer, and Jude Onyia - Chief Scientific Officer. Dimitri E. Grigoriadis reports to Kevin C. Gorman, CEO.